BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, April 5, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

July 12, 2001

View Archived Issues

SciClone's Zadaxin receives expanded approval in Mexico

Read More

Gene synthesis patent licensed by Blue Heron

Read More

S-34211: an orally available direct thrombin inhibitor with potent antithrombotic properties

Read More

Safe and effective heparin/LMWH antidote developed at Commonwealth Biotechnologies

Read More

P2T antagonist AR-C69931 acts synergistically with PGE1 to inhibit Ca2+ mobilization in platelets

Read More

ML-3000 inhibits PMN/platelet interactions in vitro

Read More

Factor VIII retroviral construct safe and potentially effective in hemophilia A patients

Read More

Blood outgrowth endothelial cell-based gene therapy for hemophilia tested in mice

Read More

Human factor VIII-expressing gutless adenovirus vector for hemophilia A

Read More

Genencor and Epimmune to codevelop vaccines for three oncogenic viruses

Read More

Company Profile: Diabetogen

Read More

Beneficial effects reported for T-588 in animal model of ALS

Read More

NDS filed for d-methylphenidate in Canada for ADD and ADHD

Read More

Immtech International achieves several milestones during fourth quarter

Read More

TheraCIM h-R3 enters phase I/II for additional indication

Read More

Selective iNOS inhibitor Ono-1714 ameliorates pancreatitis

Read More

Peripheral-type cannabinoid receptor ligand shows efficacy in acute pancreatitis

Read More

Oral thrombin inhibitors designed at Knoll (Abbott) inhibit both free and fibrin-bound thrombin

Read More

OrthoLogic extends Chrysalin license

Read More

Combined PDE3/PDE4 inhibitor therapy for obesity

Read More

Bezafibrate: the first oral agent with antiinflammatory and antiviral activity in HCV

Read More

Allergan claims new cyclopentane derivatives for glaucoma management

Read More

CRF antagonists and their therapeutic application reported by Pfizer

Read More

Joint research at Japanese labs leads to new series of sphingomyelinase inhibitors

Read More

Pharmacological profile of new NK1 receptor antagonist from Roche

Read More

Potent GABA-A agonists identified by Merck in a series of pyrazolotriazines

Read More

GABA-A receptor ligands useful for anxiety, convulsions described by Merck

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 2, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 31, 2026
  • Hengrui discovers new Nav1.8 blockers

    BioWorld Science
    Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
  • Cancer and blood cells

    Hematopoietic stem cell research points to leukemia’s early roots

    BioWorld Science
    Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
  • Illustration of a nerve cell with DNA double helix

    Molecular signatures show subtypes in neurodegenerative diseases

    BioWorld Science
    Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing